Sichuan Biokin Pharmaceutical Enrolls First Patient in Phase 3 Trial of Anti-Cancer Treatment; Shares Slide 3%
Sichuan Biokin Pharmaceutical Enrolls First Patient in Phase 3 Trial of Anti-Cancer Treatment; Shares Slide 3%
四川倍康药业招募第一位抗癌治疗三期临床试验患者；股价下滑3%。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间